articleThe LancetMay 1, 2009Closed access

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

McMaster University · Weill Cornell Medical College in Qatar · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

979
total citations
FWCI
94.39
Percentile
100%
References
20
Citations per year

Authors

13

Topics & keywords

Keywords
  • Rivaroxaban
  • Medicine
  • Venography
  • Pulmonary embolism
  • Surgery
  • Deep vein
  • Arthroplasty
  • Thrombosis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.